Leuprolide and condition aggravated 
Leuprolide and condition aggravated Patient Reports February 12, 2012
Leuprolide Side Effects Report #5450973-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2007. Female patient, 43 years of age, was diagnosed with uterine leiomyoma and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, hyperthyroidism. Leuprolide dosage: 1.88 MG (1.88 MG,1 IN 28 D). During the same period patient was treated with CANDESARTAN CILEXETIL, CALSLOT, MERCAZOLE. Patient recovered.
Leuprolide Side Effects Report #5467867-X
Leuprolide side effect was reported by a Physician from JAPAN on Sept 19, 2007. Female patient, 43 years of age, was diagnosed with uterine leiomyoma and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal pain upper, basedow's disease, condition aggravated, hyperhidrosis. Leuprolide dosage: 1.88 MG (1.88 MG, 1 IN 28 D). During the same period patient was treated with BLOPRESS, CALSLOT, MERCAZOLE, INDERAL, ALTAT. Patient recovered.
Leuprolide Side Effects Report #5863027-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2008. Male patient, 83 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, prostatic specific antigen increased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, FLUTAMIDE, ESTRAMUSTINE PHOSPHATE. Patient died on 01/08/2008.
Leuprolide Side Effects Report #5491375-3
Leuprolide side effect was reported by a Health Professional from JAPAN on Oct 12, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, delirium, dementia
, disease progression. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTAEOUS. During the same period patient was treated with CASODEX, OXYCONTIN, MAGNESIUM OXIDE, DUROTEP PATCH, ALLELOCK, PURSENNID. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5518067-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, condition aggravated, constipation
, delirium, dementia , insomnia, restlessness. Leuprolide dosage: 11.25 MG (11.25 MG,1 IN 12 WK). During the same period patient was treated with CASODEX, OXYCONTIN, MAGNESIUM OXIDE, DUROTEP PATCH, ALLELOCK, PURSENNID. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5170501-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 30, 2006. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, renal failure acute. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK); SUBCUTANEOUS. During the same period patient was treated with CASODEX, ARTIST, ALDACTONE, ACECOL, OMEPRAL, NU LOTAN, FERROMIA, PURSENNID. Patient recovered.
Leuprolide Side Effects Report #5395634-4
Leuprolide side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure congestive, cardiomegaly, condition aggravated, dyspnoea, haemodialysis, heart rate irregular, oedema, oxygen saturation decreased. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEC, ARTIST, ALDACTONE, ACECOL, OMEPRAL, LOSARTAN POTASSIUM, FERROMIA, PURSENNID. Patient recovered.
Leuprolide Side Effects Report #5877838-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv, gastric ulcer, gastritis, hypertension and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, prostate cancer
. Leuprolide dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, ESTRAMUSTINE PHOSPHATE, DECADRON SRC, REBAMIPIDE, VALSARTAN, AMLODIPINE. Patient was hospitalized. Patient died on 10/17/2007.Leuprolide Side Effects Report #4830516-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 11, 2005. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood testosterone increased, condition aggravated, nerve compression, pituitary tumour benign. Leuprolide dosage: 3.75 MG SUBCUTANEOUS. During the same period patient was treated with CASODEX, CORTRIL, LEVOTHYROXINE. Patient recovered.
Leuprolide Side Effects Report #5534113-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 26, 2007. Male patient, 75 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, chest x-ray abnormal, condition aggravated, crepitations, dyspnoea exertional, hypoxia, interstitial lung disease, prostate cancer
, urge incontinence. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with BLOFRESS, CASODEX, FLIVAS, BUFFERIN. Patient died.Leuprolide Side Effects Report #5390842-0
Leuprolide side effect was reported by a Physician from JAPAN on July 10, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, metastases to central nervous system, metastases to lung, prostate cancer
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.Leuprolide Side Effects Report #5910292-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 24, 2008. Male patient, 70 years of age, was diagnosed with prostate cancer stage iv, cancer pain and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, prostate cancer
. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, MORPHINE ELIXIR, MORPHINE ELIXIR, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE, FENTANYL. Patient died.Leuprolide Side Effects Report #5500324-0
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 23, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, metastases to bone, prostatic specific antigen increased. Leuprolide dosage: 11.25 MG (11.25 MG,1 IN 12 WK), SUBCUTANEOUS ; 11.25 MG (11.25 MG,1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX, HARNAL D, FLUTAMIDE, HONVAN, ESTRAMUSTINE PHOSPHATE. Patient died.
Leuprolide Side Effects Report #5282645-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL, GASTROM. Patient was hospitalized. Patient died.
Leuprolide Side Effects Report #5314693-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, infection
, interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5377780-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 25, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: candida serology positive, condition aggravated, interstitial lung disease, no therapeutic response. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL, GASTROM. Patient was hospitalized. Patient died.
Leuprolide Side Effects Report #4875734-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, dyspepsia, gamma-glutamyltransferase increased, jaundice
. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4698035-7
Leuprolide side effect was reported by a Consumer or non-health professional from on June 16, 2005. Male patient, 64 years of age, was diagnosed with prostate cancer stage i and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic neoplasm malignant, metastases to bone. Leuprolide dosage: 3.75 MG (3.75 MG,1 IN 28 D),SUBCUTANEOUS. During the same period patient was treated with HONVAN. Patient died.
Leuprolide Side Effects Report #4686065-0
Leuprolide side effect was reported by a Consumer or non-health professional from on May 31, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, cyanosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). Patient recovered.Leuprolide Side Effects Report #4745007-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood culture positive, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, hepatic function abnormal. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.Leuprolide Side Effects Report #4772441-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, aortic aneurysm , benign prostatic hyperplasia, calcinosis, condition aggravated, cyanosis, difficulty in walking, disseminated intravascular coagulation, fall . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.Leuprolide Side Effects Report #5371352-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, pneumonia . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with ATELEC, MICARDIS, FRANDOL TAPE. Patient died.Leuprolide Side Effects Report #4951393-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 16, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, URSO, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5339502-2
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on May 22, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebrovascular accident, condition aggravated, multiple myeloma . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient died.Leuprolide Side Effects Report #4699544-7
Leuprolide side effect was reported by a Consumer or non-health professional from on June 20, 2005. Male patient, 80 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, injection site induration, injection site swelling, prostate cancer , rectal tenesmus, urinary retention. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with ESTRACYT. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5345731-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac arrest , condition aggravated, haemolysis, hyperkalaemia, myocardial infarction. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with LOXONIN, MUCOSTA, ALLOID G, GASMOTIN. Patient died.Leuprolide Side Effects Report #4820868-4
Leuprolide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 01, 2005. Male patient, 77 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, diplopia, eye swelling, eyelid ptosis, headache , nausea . Leuprolide dosage: unknown. During the same period patient was treated with OMEPRAZOLE, RISEDRONATE, ENALAPRIL, CALCIUM CARBONATE, PROCHLORPERAZINE. Patient recovered.Leuprolide Side Effects Report #5108514-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 12, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, hepatic cirrhosis, hepatitis c , jaundice , liver disorder, malaise. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28D). During the same period patient was treated with CHLORMADINONE ACETATE. Patient recovered.Leuprolide Side Effects Report #5451812-7
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Sept 05, 2007. Male patient, 73 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: acute coronary syndrome, cholestasis, condition aggravated, disseminated intravascular coagulation, haemolysis, liver disorder, metastases to bone marrow, pancytopenia. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with ATORVASTATIN CALCIUM, CASODEX, OMEPRAZOLE, SECTRAL, DISCOTRINE. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #4875291-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2005. Male patient, 70 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, prostate cancer . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.Leuprolide Side Effects Report #5873379-1
Leuprolide side effect was reported by a Health Professional from JAPAN on Sept 01, 2008. Male patient, 68 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, parkinson's disease . Leuprolide dosage: unknown. During the same period patient was treated with AMANTADINE, ENTACAPONE, IBUPROFEN, MADOPAR, PRAMIPEXOLE DIHYDROCHLORIDE, TAMSULOSIN. Patient recovered.Leuprolide Side Effects Report #5062156-X
Leuprolide side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 10, 2006. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, eye disorder, vision blurred, visual disturbance, vitreous floaters. Leuprolide dosage: 7.5 MG (1 IN 1 M). Patient recovered.Leuprolide Side Effects Report #5485441-6
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on Oct 05, 2007. Female patient, 37 years of age, was diagnosed with in vitro fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: angina pectoris, condition aggravated, schizoaffective disorder, sleep disorder
. Leuprolide dosage: 1 MG (1 MG, DAILY, INJECTION); SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5242189-0
Leuprolide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 02, 2007. Female patient, 36 years of age, was diagnosed with endometriosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: arthropathy, condition aggravated, conjunctival haemorrhage, hypotrichosis, joint dislocation, lethargy, pain of skin. Leuprolide dosage: unknown. During the same period patient was treated with TIBOLONE. Patient recovered.Leuprolide Side Effects Report #4831699-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 11, 2005. Female patient, 44 years of age, was diagnosed with breast cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, depressed level of consciousness, depression , menopausal symptoms. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NOLVADEX. Patient recovered.Leuprolide Side Effects Report #4941616-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 03, 2006. Female patient, 44 years of age, was diagnosed with breast cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood oestrogen decreased, condition aggravated, depressed level of consciousness, depression , menopause . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NOVALDEX. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4805918-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 14, 2005. Female patient was diagnosed with breast cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, decreased appetite, depressed level of consciousness, depression , dizziness . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5104109-9
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Aug 31, 2006. Male patient, 80 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: asthenia, blood potassium increased, condition aggravated, confusional state, hypocalcaemia, impaired self-care, prostate cancer
. Leuprolide dosage: 11.25 MG. During the same period patient was treated with CLASTOBAN, ANANDRON. Patient recovered.